Skip to main content

Table 3 OR for operative vaginal delivery in women augmented with oxytocin, compared to women not augmented, before and after the intervention. Women with caesarean sections are excluded

From: De-medicalization of birth by reducing the use of oxytocin for augmentation among first-time mothers – a prospective intervention study

  OVD SVD OR/CI Unadjusted p-value Unadjusted OR/CI Adjusted b p-value Adjusted
Before the intervention N = 402 Oxytocina,bn = 241 90 (34%) 151 3.1(1.9 -5.1) < 0.001 2.1 (1.1-4.0) 0.026
No oxytocin n = 161 26 (10%) 135   1 (ref)   
After the intervention N = 596 Oxytocina,bn = 288 107 (32%) 181 4.7 (2.9 -6.8) < 0.001 2.7 (1.6-4.5) < 0.001
No oxytocin n = 308 36 (11%) 272   1 (ref)   
  1. CS: n = 29 before and n = 68 after the intervention are excluded
  2. a Oxytocin for more than 20 min
  3. b Adjusted for labor duration, birth weight and epidural
  4. Response variables: OVD operative vaginal delivery, SVD spontaneous vaginal delivery